11.04.2011 • Product

AkzoNobel Presents Your Chlorine and mTA-Salt

At 8th International Chlorine Technology Conference & Exhibition in Budapest, AkzoNobel presented two innovative concepts :

Your Chlorine is intended to re-invent the chlorine supply chain. It is designed to be the ideal solution for companies that need a chlorine supply of intermediate volumes.

General manager of AkzoNobel's Chlor-Alkali business, Martin Riswick, described the advantages of their new service, explaining that AkzoNobel would take care about everything by controlling and operating with their exacting operation standards. This way the customer's safety profile is ought to be enhanced.

Riswick published his concept by guaranteeing a continuous flow of chlorine. With Your Chlorine, AkzoNobel also offers customers an economically viable way to convert the use of outdated mercury plants to state-of-the-art membrane technology.

Industrial Chemicals showcased its innovative mTA-Salt with the ability to save up to 5% of a chlorine production plant's total energy consumption and thus improves its CO2  - footprint.

Peter Kuiipers, general manager of AkzoNobel's Salt business, said that mTA-Salt had become exceedingly attractive to companies running membrane electrolysis. Another benefit that was named in this interview was the increase of the membrane cells lifespan and its production, plus the fact that it enhances the safety profile of chlorine plants.

Company

AkzoNobel Industrial Chemicals

Stationsstraat 77 / P.O. Box 247
3800 AE Amersfoort
Netherlands

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read